MoneyWorks4Me

Bharat Parenterals - Quaterly Results

06 Aug 2026 Evaluate
The Sales for the quarter ended June 2026 of Rs. 555.01 million declined by -41.19% from Rs. 943.69 millions.Net Profit of the company move down -63.43% to Rs. 36.57  millions from Rs. 99.99 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 78.78 millions from 168.74 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 555.01 943.69 -41.19 555.01 943.69 -41.19 2340.15 3041.34 -23.06
Other Income 10.53 16.20 -35.00 10.53 16.20 -35.00 125.52 145.48 -13.72
PBIDT 78.78 168.74 -53.31 78.78 168.74 -53.31 336.43 481.53 -30.13
Interest 6.93 14.17 -51.09 6.93 14.17 -51.09 34.35 47.85 -28.21
PBDT 71.85 154.57 -53.52 71.85 154.57 -53.52 302.08 433.68 -30.34
Depreciation 22.55 20.58 9.57 22.55 20.58 9.57 83.65 70.52 18.62
PBT 49.30 133.99 -63.21 49.30 133.99 -63.21 218.43 363.16 -39.85
TAX 12.73 34.00 -62.56 12.73 34.00 -62.56 58.24 98.62 -40.95
Deferred Tax -2.92 -3.04 -3.95 -2.92 -3.04 -3.95 -11.34 -7.20 57.50
PAT 36.57 99.99 -63.43 36.57 99.99 -63.43 160.19 264.54 -39.45
Equity 68.92 68.90 0.03 68.92 68.90 0.03 68.92 68.92 0.00
PBIDTM(%) 14.19 17.88 -20.62 14.19 17.88 -20.62 14.38 15.83 -9.20

Bharat Parenterals Share Price

1375.00 -44.35 (-3.12%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: